{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Active+Mask&page=10", "query": { "intervention": "Active Mask", "page": 10 }, "page_size": 10 }, "pagination": { "page": 10, "page_size": 10, "total_count": 354, "total_pages": 36, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Active+Mask&page=11&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Active+Mask&page=9&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-23T06:50:14.648Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01639846", "title": "Evaluation of the Onset and Duration of Action of RX-10045 in Allergic Conjunctivitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Allergic Conjunctivitis" ], "interventions": [ { "name": "RX-10045", "type": "DRUG" }, { "name": "Vehicle for RX-10045 arm", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "C.T. Development America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2012-07", "completion_date": "2012-08", "has_results": false, "last_update_posted_date": "2013-02-08", "last_synced_at": "2026-10-23T06:50:14.648Z", "location_count": 1, "location_summary": "Andover, Massachusetts", "locations": [ { "city": "Andover", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01639846" }, { "nct_id": "NCT06411561", "title": "A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Critical Illness", "Delirium", "Cognitive Impairment", "Cognitive Decline", "Alzheimer's Disease", "Dementia", "Circadian Dysrhythmia", "Sleep Disturbance" ], "interventions": [ { "name": "SLEEP + COG", "type": "BEHAVIORAL" }, { "name": "COG", "type": "BEHAVIORAL" }, { "name": "SLEEP", "type": "BEHAVIORAL" }, { "name": "AC", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 100, "start_date": "2024-12-26", "completion_date": "2027-05-31", "has_results": false, "last_update_posted_date": "2025-07-20", "last_synced_at": "2026-10-23T06:50:14.648Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT06411561" }, { "nct_id": "NCT00047463", "title": "Effects of Treating Obstructive Sleep Apnea in Epilepsy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Epilepsy", "Sleep Apnea", "Obstructive Sleep Apnea" ], "interventions": [ { "name": "continuous positive airway pressure (CPAP)", "type": "DEVICE" }, { "name": "Placebo-CPAP", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Vanderbilt University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 68, "start_date": "2002-09", "completion_date": "2008-07", "has_results": true, "last_update_posted_date": "2016-07-21", "last_synced_at": "2026-10-23T06:50:14.648Z", "location_count": 4, "location_summary": "Ann Arbor, Michigan • Chapel Hill, North Carolina • Cleveland, Ohio + 1 more", "locations": [ { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00047463" }, { "nct_id": "NCT05151744", "title": "A Study to Investigate Vamikibart (RO7200220) in Combination With Ranibizumab in Diabetic Macular Edema", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetic Macular Edema" ], "interventions": [ { "name": "Vamikibart", "type": "DRUG" }, { "name": "Ranibizumab", "type": "DRUG" }, { "name": "Sham Procedure", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 187, "start_date": "2021-12-17", "completion_date": "2024-10-01", "has_results": true, "last_update_posted_date": "2025-10-16", "last_synced_at": "2026-10-23T06:50:14.648Z", "location_count": 10, "location_summary": "Arcadia, California • Torrance, California • Walnut Creek, California + 7 more", "locations": [ { "city": "Arcadia", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Melbourne", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05151744" }, { "nct_id": "NCT05752942", "title": "Precision-Based Approach to Matching Evidence-Based Interventions to Students With Externalizing Behaviors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Problem;Behaviour;Child" ], "interventions": [ { "name": "Student Intervention Matching System (SIMS)", "type": "BEHAVIORAL" }, { "name": "group-based social skills training", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Iowa", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "9 Years", "maximum_age": "12 Years", "sex": "ALL", "summary": "9 Years to 12 Years" }, "enrollment_count": 51, "start_date": "2018-08-25", "completion_date": "2018-12-01", "has_results": false, "last_update_posted_date": "2023-03-03", "last_synced_at": "2026-10-23T06:50:14.648Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT05752942" }, { "nct_id": "NCT04935606", "title": "mHealth to Enhance & Sustain Drug Use Reduction of the QUIT BI in Primary Care", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Drug Use" ], "interventions": [ { "name": "Usual Care", "type": "BEHAVIORAL" }, { "name": "QUIT Intervention (doctor brief advice, video doctor, health coaching sessions at 2- and 6-weeks)", "type": "BEHAVIORAL" }, { "name": "QUIT-Mobile (QUIT Intervention plus weekly mobile-web app or text message weekly self-monitoring, automated feedback over 12 months)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of California, Los Angeles", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 457, "start_date": "2021-06-01", "completion_date": "2026-06-30", "has_results": false, "last_update_posted_date": "2026-07-30", "last_synced_at": "2026-10-23T06:50:14.648Z", "location_count": 5, "location_summary": "Long Beach, California • Los Angeles, California", "locations": [ { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04935606" }, { "nct_id": "NCT04592419", "title": "A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Macular Edema", "Retinal Vein Occlusion" ], "interventions": [ { "name": "KSI-301", "type": "DRUG" }, { "name": "Aflibercept", "type": "DRUG" }, { "name": "Sham Procedure", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Kodiak Sciences Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 568, "start_date": "2020-09-25", "completion_date": "2023-01-19", "has_results": true, "last_update_posted_date": "2024-06-26", "last_synced_at": "2026-10-23T06:50:14.648Z", "location_count": 81, "location_summary": "Phoenix, Arizona • Beverly Hills, California • Fresno, California + 75 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "Fullerton", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04592419" }, { "nct_id": "NCT02378467", "title": "Saline Hypertonic in Preschoolers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cystic Fibrosis" ], "interventions": [ { "name": "7% Hypertonic Saline (HS)", "type": "DRUG" }, { "name": "0.9% Isotonic Saline (IS)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Washington, the Collaborative Health Studies Coordinating Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "5 Years", "sex": "ALL", "summary": "3 Years to 5 Years" }, "enrollment_count": 150, "start_date": "2015-03-01", "completion_date": "2018-08-31", "has_results": false, "last_update_posted_date": "2020-01-14", "last_synced_at": "2026-10-23T06:50:14.648Z", "location_count": 23, "location_summary": "Birmingham, Alabama • Palo Alto, California • Aurora, Colorado + 20 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Palo Alto", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Orlando", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02378467" }, { "nct_id": "NCT05745064", "title": "A Study of TL-925 as a Treatment for Dry Eye Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dry Eye Disease" ], "interventions": [ { "name": "TL-925", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Telios Pharma, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 107, "start_date": "2023-02-27", "completion_date": "2023-07-11", "has_results": false, "last_update_posted_date": "2023-11-18", "last_synced_at": "2026-10-23T06:50:14.648Z", "location_count": 4, "location_summary": "Newport Beach, California • Colorado Springs, Colorado • Indianapolis, Indiana + 1 more", "locations": [ { "city": "Newport Beach", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Andover", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05745064" }, { "nct_id": "NCT03293992", "title": "A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Glaucoma, Open-angle", "Ocular Hypertension" ], "interventions": [ { "name": "0.01% RO7058584", "type": "DRUG" }, { "name": "0.1% RO7058584", "type": "DRUG" }, { "name": "1% RO7058584", "type": "DRUG" }, { "name": "Matching Placebo", "type": "DRUG" }, { "name": "Latanoprost 0.005%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 27, "start_date": "2017-10-10", "completion_date": "2017-12-21", "has_results": false, "last_update_posted_date": "2020-03-31", "last_synced_at": "2026-10-23T06:50:14.648Z", "location_count": 8, "location_summary": "Chandler, Arizona • Artesia, California • Inglewood, California + 5 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Artesia", "state": "California" }, { "city": "Inglewood", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03293992" } ] }